Nanopharm’s Interhale technologies are innovative approached for the development of formulation systems for inhaled products that enable control, modulation and reproducibility in aerosolised drug delivery performance.
Nanopharm Interhale technologies leverage our understanding of particulate systems and formulation processing operations to design structured formulation systems for orally inhaled and nasal products.
These formulation systems have been successfully applied to a wide variety of APIs from early phase development through to pilot and pivotal scales.
Our Interhale formulation technologies are centered on ensuring consistency in performance and have been successfully applied in formulation development of a range of orally inhaled and nasal drug products through to clinical trials.
Our non-proprietary platforms have been applied to a wide variety of therapeutic drugs and inhaler devices, to meet the specific target product profiles desired by clients.